Look for pharmaceutical and biotech companies to make news this week as a UBS industry conference kicks off in New York. Also, Merrill Lynch analysts believe pricing power for prescription drugs is returning. What’s the trade?
Guy Adami likes Pfizer (PFE) because he feels it’s cheap right now.
Pete Najarian recommends Myraid Genetics (MYGN) as well as Quest Diagnostics (DGX) for preventative medicine.